Law on Medical Examination & Treatment in force
Replaces the 2009 law; introduces a 5-year practising certificate validity, a CME mandate, and establishes the National Medical Council as the body that will run the future licensing exam.
Regulatory calendar
A chronological view of recent and upcoming Vietnamese regulatory milestones across pharma, cosmetic, food and medical practice. Each milestone shows the governing document, affected product kinds and a link to a Medibase deep-dive article when one exists.
| Effective date | Document ID | Name | Affected kinds |
|---|---|---|---|
| 2024-01-01 | Law 15/2023/QH15 | Law on Medical Examination & Treatment in force | practice |
| 2024-11-21 | Law 44/2024/QH15 | Pharmacy Law amendment passed | drug |
| 2025-01-01 | Decree 96/2023/ND-CP | Three-tier medical facility system in force | practice |
| 2025-07-01 | Law 44/2024/QH15 | Pharmacy Law amendment effective | drug |
| 2025-07-01 | Decree 163/2025/ND-CP | Decree implementing the amended Pharmacy Law in force | drug |
| 2025-07-01 | Circular 31/2025/TT-BYT | Drug-registration procedure circular | drug |
| 2025-07-01 | Circular 28/2025/TT-BYT | GMP for drug manufacturing — refreshed | drug |
| 2025-07-01 | Circular 11/2025/TT-BYT | Good Pharmacy Practice — consolidated text | drug |
| 2025-10-25 | Circular 40/2025/TT-BYT | Public-hospital drug procurement — refreshed | drug, tender |
| 2025-12-31 | Hague Apostille Convention 1961 | Vietnam deposits accession to the Hague Apostille Convention | medical_device, drug, treaty |
| 2026-01-01 | Law 112/2025/QH15 | Terminology law for the medical-practitioner exam | practice |
| 2026-01-26 | Decree 46/2026/ND-CP | Food-safety decree signed and originally effective | food, supplement |
| 2026-02-04 | Resolution 09/2026/NQ-CP | NQ 09/2026 suspends Decree 46/2026 (initially until 15 April 2026) | food, supplement |
| 2026-02-27 | Circular 50/2025/TT-BYT | Clinical-trial application procedure refreshed | drug |
| 2026-04-06 | Resolution 15/2026/NQ-CP | NQ 15/2026 extends suspension of Decree 46/2026 indefinitely | food, supplement |
| 2026-04-29 | Resolution 21/2026/NQ-CP | Food-advertising approval delegated to provinces | food, supplement |
| 2026-06-01 | Circular 18/2026/TT-BYT | Special-control medicines circular signed | drug |
| 2026-07-01 | Resolution 21/2026/NQ-CP | Practice-licensing & advertising authority moves to provinces | practice |
| 2026-07-16 | Circular 18/2026/TT-BYT | Special-control medicines — full effect | drug |
| 2026-09-11 | Hague Apostille Convention 1961 | Hague Apostille Convention in force for Vietnam | drug, medical_device, treaty |
| 2026-10-01 | Circular 32/2026/TT-BYT | Circular 32/2026/TT-BYT — new drug-registration framework in force | drug |
| 2027-01-01 | National Medical Council | National Medical Licensing Examination operational | practice |
| 2027-07-01 | Circular 32/2025/TT-BYT | Traditional-medicine licensing fully delegated to provinces | drug |
| 2032-01-01 | Law 15/2023/QH15 | Vietnamese-language requirement hardens for foreign practitioners | practice |
Replaces the 2009 law; introduces a 5-year practising certificate validity, a CME mandate, and establishes the National Medical Council as the body that will run the future licensing exam.
National Assembly passes the Pharmacy Law amendment (amends Pharmacy Law 105/2016); takes effect 1 July 2025.
A primary / basic / specialised three-tier system replaces the legacy four-tier scheme; reshapes referral pathways and health-insurance entitlement.
Automatic-extension safety net for in-flight renewals, explicit reference-dossier pathway for SRA-approved products, 3-month renewal window (down from 12), dedicated innovative-drug pathway.
Implements Law 44/2024: special-control drug classification, storage / production / distribution rules, FIE notification regime (Art. 91 §12).
Operational circular for Pharmacy Law Chapter IV — dossier modules, timelines, expert-council process.
Replaces Circular 35/2018/TT-BYT with an updated GMP framework aligned to PIC/S developments.
Consolidated GPP text integrated with the electronic drug-records requirement.
Vietnam deposits the instrument of accession to the 1961 Hague Apostille Convention; replaces consular legalisation for most public documents from foreign signatories — major simplification for FSC / CPP / GMP packs.
Terminology update preparing the legal framework for the National Medical Licensing Examination (NMLE) pilot.
Signed and originally effective for 9 days before being suspended on 2026-02-04 (see next entry). Would have replaced Decree 15/2018/ND-CP — self-declaration → conformity registration, packaging brought in-scope, HACCP / GMP / ISO 22000 mandate by 31 Dec 2026 — but none of those obligations are currently operating. Decree 15/2018 continues to apply.
Resolution 09/2026/NQ-CP suspends Decree 46 (and Resolution 66.13/2026/NQ-CP on product declaration) following the customs-clearance crisis. Decree 15/2018 continues to apply. The 75-day window was subsequently extended indefinitely by NQ 15/2026 — see the 6 April 2026 entry.
Replaces Circular 50/2018; tightens timelines and aligns with ICH expectations for first-in-human and reference-product trials.
Resolution 15/2026/NQ-CP extends the suspension of Decree 46/2026 (and Resolution 66.13/2026/NQ-CP) until the revised Food Safety Law and its implementing decrees take effect. Decree 15/2018 continues to apply; dossiers filed before this resolution are handled per Decree 15/2018. The revised Food Safety Law is expected at the September 2026 UBTVQH session (Resolution 119/2026/UBTVQH15).
Delegates food-advertising approval authority from the central VFA to provincial UBND; takes operational effect 1 July 2026.
Implementing circular for the special-control medicines regime. Etomidate and Carisoprodol reclassified as psychotropic effective immediately on signature; other provisions wait for 16 July 2026.
practising certificate issuance moves from MOH to the provincial People's Committee Chairperson; food-advertising approval operationally devolves to provinces; partial BHYT cover begins for select cross-tier outpatient services.
Procedures, storage rules, prescription / dispensing / disposal controls under TT 18/2026/TT-BYT all become active.
Apostille replaces consular legalisation for public documents from other signatories — direct simplification for FSC / CPP / GMP and medical-device technical files.
Replaces Circular 12/2025/TT-BYT as the operational rulebook for marketing authorisation of chemical drugs, vaccines, biologicals, herbal medicines, and pharmaceutical starting materials. Traditional medicine continues under Circular 29/2025/TT-BYT — not in scope of 32/2026. Transitional provisions for in-flight dossiers filed before 1 October 2026 expected in DAV implementation guidance.
The NMLE under the National Medical Council becomes the mandatory route for new practising certificate issuance for doctors. Exact rollout date phased under Law 15/2023 framework — confirm against MOH announcements.
End of the 12-month transition (from 1 July 2026) — registration of processed traditional medicinal ingredients and medicinal materials is fully handled at the provincial Department of Health.
End of the deferred transition: foreign healthcare practitioners must satisfy the Vietnamese-language proficiency requirement to maintain practising certificate.